Your browser does not support HTML5.
Display of the content may be incorrect.
Please make sure that your browser supports HTML5 syntax.
Chemspace is a provider of small molecules and drug discovery research services through its subsidiaries and partners. Our goal is to deliver high-quality drug discovery solutions to our clients.
News and Events
19 October 2018
In September 2018, FDA approved VIZIMPRO (dacomitinib) for lung cancer treatment. It contains very simple 3-chloro-4-fluoroaniline moiety in its backbone.More»
3 October 2018
Fluorine containing cyclobutanamines
In July 2018, FDA approved TIBSOVO (ivosidenib) as an acute myeloid leukemia drug. It contains acylated 3,3-difluorocyclobutan-1-amine moiety in its backbone.More»
2 October 2018
LUCEMYRA (lofexidine hydrochloride)
In May 2018, FDA approved LUCEMYRA as a drug to treat opioid withdrawal symptoms. It contains 4,5-dihydro-1H-imidazole moiety in its backbone, which is quite uncommon for drugs.More»